Girl Gets Early Lymphoma Diagnosis Thanks to Mascara

At least one teenager can make a case that applying make-up early is a lifesaver.

A 16-year-old girl from north Yorkshire, Faye Archer, reportedly had her life saved simply as a result of her using mascara.

Apparently, while applying mascara to one of her eyes, Archer somehow developed an infection. Then, while undergoing a series of treatment options for her infection, doctors found that she was suffering from Hodgkin’s lymphoma, a cancer of the lymph nodes.

The cancer was caught early, and because of this, treatment ended up going off without a hitch.

Speaking with the Yorkshire Evening Post, Archer had this to say on the matter:

"Wearing mascara really did save my life.

"If I hadn't got the eye infection I would never have had the tests and the cancer may not have been found in time."

Faye’s mother, Sue, admitted that the family would have never known about the cancer if the eye infection had not developed.

Realizing how lucky they were, the family wants to give back. Now, with their newfound notoriety, they are attempting to raise money for the Leukaemia and Lymphoma Research and Bone Cancer Research Trust with a summer ball and fashion show.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap